Navigation Links
CARDIA Studies Open Window on Heart, Lung Diseases
Date:5/22/2008

Researchers analyze different proteins in progression of risk factors as subjects aged

THURSDAY, May 22 (HealthDay News) -- New insights into lung disease and lung function in young adults are provided in two new studies.

The researchers analyzed data from the U.S. National Heart, Lung, and Blood Institute's CARDIA (Coronary Artery Risk Development in Young Adults) observational cohort, which recently completed 20 years of health assessments in more than 5,000 young adults.

The participants were healthy 18- to 30-year-olds when CARDIA was launched in 1985 and 1986. CARDIA was designed to look for cardiovascular trouble and lung disease risk factors as the participants aged.

One of the studies identified an association between low levels of a protein called adiponectin in fat cells to increased asthma risk in young women. Even though adiponectin is produced by fat cells, obesity may trigger an inflammatory response to the protein. Its production is diminished in obese people, and its levels increase with weight loss.

For this study, researchers divided 2,890 men and women into three groups, according to the amount of adiponectin produced by their fat cells.

Women with the lowest levels of adiponectin, who also tended to be more obese, had almost double the risk of developing asthma compared to women who had the highest levels of adiponectin. This was true regardless of weight, and the association was most evident in premenopausal women.

No similar association between adiponectin levels and asthma was noted in men.

"Our finding that adiponectin may have a protective effect on asthma in women may open up doors to new ways of treating asthma. The findings have particular relevance for obese women, since they are more likely to have low blood adiponectin concentrations," lead researcher Dr. Akshay Sood, an associate professor in the division of pulmonary and critical care medici
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
3. Family History Has Strong Effect on Cardiac Risk
4. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
5. Cardiac Science to Present at the UBS Global Life Sciences Conference
6. Cardiac Science Applauds Mass AED Training of Pittsburgh Educators
7. Guidelines help patients reduce risk of cardiac event before surgery
8. Cardiac Science Named to Deloittes Technology Fast 50 for Washington State
9. Cleveland Clinic and The Larry King Cardiac Foundation Partner to Provide Heart Surgery to Those in Need
10. Cardiac Science Releases New Cardiac Rehabilitation System
11. Cardiac Artery Trouble Boosts Family Heart Risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ial congress of the European Association of Echoca...ean Society of Cardiology, where techniques of non..., New case reports will be presented at this year... the role of this new technology. , Now, with s... likely that non-invasive imaging will gain more i...
(Date:12/2/2009)...tional Pen ( www.pens.com ), a worldwide leading p...s giving away 10,000 free business card pens. , ... National Pen ( www.pens.com ), a worldwide leadin... is giving away 10,000 free business card pens. , ...ss that no other company in the industry can do, a...
(Date:12/2/2009)...volutionary new cell phones that direct microwave ...able in early 2010 from Aerius International Ltd. ...09 -- Revolutionary new cell phones that direct mi...be available in early 2010 from Aerius Internation... Green Technology Award in wireless communication ...
(Date:12/2/2009)... Sunday, more than 900 runners and walkers from La...sh line at the Rock ‘n’ Roll Las Vegas... $3.2 million for the Crohn,s & Colitis Founda...eam Challenge (www.ccteamchallenge). As the offici...esearch, education, and support initiatives to ben...
(Date:12/2/2009)... The American Health Inf...rs today announced Alan F. Dowling, PhD, will be t...h information management (HIM) leader. Dr. Dowlin...es academia, systems management, strategic experti...ecutive leadership. He is scheduled to take offic...
Breaking Medicine News(10 mins):Health News:Media alert: EUROECHO 2009 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2
...onwealth, HARRISBURG, Pa., Feb. 7 A Harrisburg-b...ut promising Pennsylvania,pharmaceuticals, biotech...st track for growth, Governor Edward G. Rendell sa...world," the Governor said. "Over the past,five yea...
...al Health Top the List,of Needs, WASHINGTON, Feb....es in decades, many people across the south are,be...Cross continues to help,provide meals, shelter and...sionate volunteers lend physical and,emotional sup...
...unce the,appointment of Paul Barnes to the newly c...rch (PSLR)., In his new role, Mr. Barnes will lea...existing research businesses: P\S\L Research Inter...full,potential, and also to develop new research a...
...hwestern University,s Feinberg School of Medicine ...t patients in respiratory distress in hospital int...d that high levels of carbon dioxide (CO2) or hype...ted levels of CO2 actually have the opposite effec...
... seemingly random arterial abnormality that can ca...o previous symptoms may not be so random after all...ered that many people with congenital aneurismal f...art Disease. , The authors were inspired to searc...
...unt (Mo.) issued the following statement today in ...leana Ros-Lehtinen (R-Fla.), Chris Smith,(R-N.J.),...r money being,used to fight HIV/AIDS abroad isn,t ...h this Congress has,demonstrated an overwhelming a...
Other Medicine News:Health News:Pennsylvania Gov. Rendell: $10 Million Partnership With Harrisburg Venture Capital Firm Boosts PA's Life Sciences Industry 2Health News:Tornado-Scarred States Receive American Red Cross Health Services 2Health News:Tornado-Scarred States Receive American Red Cross Health Services 3Health News:P\S\L Group appoints Paul Barnes as Group President P\S\L Research 2
(Date:12/2/2009)... , KNOXVILLE, Tenn., Dec. 2 ...m ), a division of the nation,s largest provider o...t has signed two contracts to provide teleradiolog...linois. ,, An agreement signed with UpState Car... allow TeamHealth Teleradiology to provide service...
(Date:12/2/2009)... , PHILADELPHIA, Pennsylvania, December 2 ...DAQ: SHPGY ), the global specialty biopharmaceuti...igation with Teva,Pharmaceuticals USA, Inc. ("Teva...neric version of ADDERALL XR. Shire has been suppl...e April 1, 2009. Shire,s ability to supply,the pro...
(Date:12/2/2009)... , ROCKVILLE, Md., Dec. 2 /PRNewswire-FirstCall... favorable initial results from the first stage of... safety and immunogenicity of the company,s 2009 H...accine. Novavax is conducting this study in colla...port registration of the vaccine in Mexico and pot...
Breaking Medicine Technology:TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Aegis Living Chosen as Best Retirement Facility in 2009 Best of 425 magazine 55950 1Aegis Living Chosen as Best Retirement Facility in 2009 Best of 425 magazine 55950 2Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 1Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 2Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 3Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 4United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 1United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 2
... and Disease-Free Survival -, WAYNE, N.J., June 5...noma patients demonstrated that a majority of pati...ed disease-free and/or overall,survival. These fin...cancer,setting, were released at the 44th annual m...y (ASCO)., Results from the Phase II study (ASCO ...
...t International Conference on Malignant L...y, BETHESDA, Md., June 5 Micromet, Inc. (Nasdaq:...el, proprietary antibodies,for the treatment of ca...presented an update of an ongoing phase 1 clinical...3/MEDI-538) at the 10th International Conference,o...
Other Medicine Technology:Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 2Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 3Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 4Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 5Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 2Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 3Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 4Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 5
TSH Receptor (TSHR) Autoantibody - RIA
TSH Receptor (TSHR) Autoantibody - ELISA
TSH Receptor (TSHR) Autoantibody Coated-Tube (CT)
Thyroid Peroxidase (TPO) Autoantibody - RIA
Medicine Products: